Johnson & Johnson Pays $6 Billion In Ovarian Cancer Lawsuit

( – Johnson & Johnson said that it would offer to pay six billion dollars to settle allegations that its talc product causes ovarian cancer. This resolution is supposed to resolve deceased litigation over the brand and its products.

Thousands of lawsuits accused Johnson & Johnson of selling products that caused ovarian cancer in women, which in some cases were fatal. J&J has said numerous times that their talc products are safe, even though the company stopped selling talc products years ago.

The settlement will resolve over ninety-nine percent of their talc lawsuits in the United States. The company said the cases related to mesothelioma will be handled on the side and that the proposed amount does not cover that.

“The Plan is the culmination of our consensual resolution strategy that we announced last October,” said J&J worldwide vice president of litigation, Erik Haas, “Since then, the Company has worked with counsel representing the overwhelming majority of talc claimants to bring this litigation to a close, which we expect to do through this plan.”

Johnson & Johnson said that the settlement would be part of a bankruptcy reorganization plan for a subsidiary; they’d give ovarian cancer patients three months to vote against or for the plan. Most of the law firms support the plan, but some said that it could “cheat victims legitimately harmed by talc.”

Head of the Mass Torts Section at the Beasley Allen Law Firm, Andy Birchfield, said, “We believe any bankruptcy based on this solicitation and vote will be found fraudulent and filed in bad faith under the Bankruptcy Code.”

Copyright 2024,